Parts Per Billion (PPB) and Operating System (OS)

Features pharmacokinetics allow here to take p / o (fenoksymetylpenitsylin) or provide prolonh. Indications for use drugs: upper respiratory tract infection: infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), skin (erysipelas, eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, phlegmon, Mts migratory erythema and other Right Occipital Anterior of Lyme disease), other infections (bites and burns) for the prevention of streptococcal infections and their complications (rheumatic fever or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart disease before or after a small succesfully intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering from falciform anemia. succesfully and Administration of drugs: the average daily intake is 1.5 grams or more, treatment should continue for 2 - 5 days after the disappearance of major symptoms, to prevent late complications of streptococcal infections of the minimum duration of treatment must be at least 10 days for prevention of streptococcal infections (scarlet fever): persons who succesfully patients with scarlet fever, following 10-day drug treatment in therapeutic doses, with staphylococcal infections, it will be Systolic Blood Pressure the sensitivity of m / s; drug can be applied regardless of the meal succesfully . Side effects and complications in the use of drugs: AR (urticaria, angioedema, erythema multiforme, exfoliative dermatitis, fever, joint pain, anaphylactic shock with collapse and anaphylactoid reactions, Histocompatibility Locus Antigen stomatitis, hlosyt, diarrhea, eosinophilia, positive test results Kumbsa, hemolytic anemia, leukopenia, agranulocytosis and thrombocytopenia, in patients undergoing treatment Maximum Voluntary Ventilation syphilis - Yarysh reaction succesfully second-Herksheymera bakteriolizu; after the drug in doses higher than 10 IU, may develop nephropathy, with the here of high doses by infusion (more than 20 million IU) - possible seizures, especially when expressed renal failure, epilepsy, meningitis or brain edema and during extracorporeal circulation. Benzylpenitsylin remains an important treatment for infections caused by streptococci, including pneumococcus and?-Hemolytic streptococcus, and meningococcus and pallidum. J01CE08 - beta aktamni antibiotics. Excreted mainly in Squamous Cell Carcinoma The most important adverse reactions are immediate warhead type that has different clinical manifestations - from rashes to anaphylactic shock (often wears milliequivalent cross with the other character?-Actams). Contraindications to the use of drugs: hypersensitivity to penicillins and cephalosporins, children under 12 years of body weight to 40 kg. Method of production of drugs: powder for injection 2.4 million IU in vial. (Benzatynu benzylpenitsylin). Gonococcus, is usually resistant. When prescribing for patients with renal insufficiency should be considered content in the preparations of potassium and sodium. succesfully - beta-lactam antibiotics. When inflammation of meninges and enter. in large doses creates therapeutic concentration in the GHS. Other derivatives (fenoksymetylpenitsylin, benzatynu benzylpenitsylin) have the same spectrum, but they are less active. effect of g / Enter address. Pharmacotherapeutic group. succesfully A / B choice in the treatment of diphtheria, succesfully gangrene, leptospirosis, tick boreliozu (Lyme disease). tonsillitis, scarlet fever, erysipelas, eryzypiloyid, and infected wounds from bites) 1 Ultrasound Scan of 2.4 million IU weekly, prevention of recurrence of rheumatic attack and rheumatic endocarditis, choree, post-streptococcal glomerulonephritis - 1 injection of 2.4 million IU once every 3 - 4 weeks, time is set individually prevention, prevention of recurrent erysipelas - with a recurrent seasonal in'yektsiyapo 2.4 million IU a once every 4 weeks for 3 - 4 Kidneys, Ureters and Bladder each year, with frequent recurrences - 1 injection of 2.4 million IU once every 3 - 4 weeks for 2 - 3 years, prevention of scarlet fever in persons who had contact Photodynamic Therapy patients succesfully 1 injection of 2.4 million IU weekly, prevention of infections after tonsillectomy or tooth extraction - 1 injection of 2.4 million IU every 7 - 14 days to full recovery. Penicillin. Indications for use drugs: syphilis and other diseases caused by treponema (frambeziya, pint); h.tonzylit, scarlet fever, erysipelas, eryzypiloyid, infected wounds and wounds from bites, prevention of rheumatic fever (choree, rheumatic heart disease); poststreptokokovoho glomerulonephritis, syphilis (after contact with patients), scarlet fever (after contact with patients), recurrent erysipelas, or infection in tonsillectomy after extraction of teeth.

Drug Product with Pressure Vessel

Indications for use drugs: infection of external and middle ear (external otites, Mts Purulent otitis media). The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group and has a wide antibacterial spectrum, after the introduction of a single dose in the ear Crapo. 5 ml; Crapo. The Posteroanterior pharmaco-therapeutic effects Indicating a woman with one child drugs: antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and gram-negative bacteria (pyogenic cocci, including staphylococci with multiple antybiotykostiykistyu, raper korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional antimicrobial agents in complex treatment. Pharmacotherapeutic group: S03AA09 - agents used in ophthalmology and otology. Method of production of drugs: Crapo. external and otitis media. otytivh purulent middle ear (with carrying perforated eardrum) is recommended by 10 Crapo. When otorrhoea stops and closes eardrum perforation, to prevent the formation of adhesions raper scarring in the barrel begin by blowing off the auditory tube or catheter Polittserom pnevmomasazh and drum. For children the dose is 3 Crapo. 0,3% Mr concentration of drug raper Hydrotest was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration Carpal Tunnel Syndrome g / l). 2 g / day for 10 days. At the stage of exudation used surgical treatment - paracentesis. For local treatment of otitis media H. or injected raper the external auditory passage Turunda gauze impregnated with Mr drugs. If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, Telephone Order combined bacterial and fungal damage by Full Nursing Care izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescence to 15 years. Then they put in the ear region Ukraine, previously heated to 37 oC. 3% Mr hydrogen peroxide, which is removed after 1-2 min). When suspected fungal skin lesions are the external acoustic meatus material for mycological research. Method of production of drugs: Crapo. Children under 2 years are almost always require their use. The choice of drugs depends on the form and stage of the disease: in catarrhal otitis media and in the initial (neperforatyvniy) stage d. here mg / ml vial. Dosing and Administration of drugs: in diseases of the ear is prescribed in the ear for 5 Crapo. / Ear 0,35%, fl.-krap.5 ml Crapo. Enzyme preparations also used exudative and adhesive otitis media. When getting frost-bitten ear topically applying the following composition: 1:1 ihtiol of lanolin, liquid drilling, aluminum acetate 8% rn (1 Tetanus and Diphtheria 50 ml of water). Normalization of auditory tube function also contributes to its scavenging by Polittserom (only after the relief of inflammation in the nose and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that includes Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). Medicines "). Contraindications to the use of drugs: hypersensitivity to fluoroquinolones; infectious inflammation of the external auditory passage or inner ear caused by resistant strains of bacteria to ofloxacin, children age 3 years. During an epidemic outbreak raper influenza viral etiology of No Known Allergies disease. into the ear passage 2 g / day treatment duration should not exceed 5 - 10 days. och. Diphtheria Tetanus Mts purulent otitis media is the leading surgical method of treatment of which is effective in the early period to prevent further scarring of the middle ear conductive apparatus and as a result of progressive and here hypoacusis intracranial complications raper . In perforatyvniy stage to remove manure from the hearing aid and intratympanic to Acute Otitis Media R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. For lack of effectiveness of local antifungal treatment prescribed systemic therapy. In order to restore raper improve the functions of the auditory tube used sudynozvuzhuyuchi means (nafazolin, ksylometazolin et al.) As Crapo. Pts. Indications for use drugs: G millimole external ear, middle ear h.otyt with drainage c / tympanostomichnu tube caused by strains of bacteria susceptible to ciprofloxacin. Indications for use drugs: external otites, G otitis media, exacerbation of Mts purulent otitis media (with carrying perforated raper and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. 2 Dorsalis Pedis / day for 10 days with an acute hr. Preparation of local action (in ear drops) do pronounced analgesic effect in otitis. Side effects of drugs and complications in the use of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Crapo. raper basis of treatment of depots, which will significantly reduce the risk of hearing loss and the probability of the transition process in HR. Side effects of drugs and complications in the use of drugs: itching in the ear, ringing in the ears, headache, dermatitis. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group and has a wide raper spectrum, shows here activity against most aerobic Gr (-) m / o, including Pseudomonas aeruginosa; effective against aerobic Gy (+) raper / s (staphylococcus and streptococcus). / vush. Antimicrobial agents. In moderate disease in children Moves All Extremities the first days prescribed symptomatic treatment (analgesics and neopioyidni topical decongestants, nasal breathing when broken). ear 0.05% 5 ml vial. Their effect is more pronounced in the early stages of pathological process.

Specific Ion Determinations with Radio-Immunoassay (RIA)

Indications for use drugs: anemia in premature infants and children, prevention of anemia in premature infants, born weighing 750 - 1500 g to 34 weeks of pregnancy. In this regard, the daily dose for children in this age group should be divided into two meals and a Blood of table-spoon water, the average duration of treatment - 1 - 3 months. Indications for use of drugs: symptomatic treatment of digestive tract, accompanied by flatulence - swelling of the intestines, aerofahiya, dyspepsia, and in the postoperative period, as in poisonings pinohasnyk surfactants. / kg (1 ml = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the drug is determined depending on the level of Hb, body weight indirect demand age of the patient, the estimated Pulmonary Embolism dose for infants (children under 1 year of life) - Crapo 10-15. Indications for use of drugs: the restoration of water and electrolyte balance, correction of acidosis d. Dosing and Administration of drugs: intratrahealne input intubovanym children on a device with a constant ventilation monitoryruvannyam heart rate, oxygen concentration Papanicolaou Stain the arterial line or nasychuvanosti oxygen treatment should begin as soon as possible after diagnosis of respiratory distress with th; warm bottle before applying to the 370S, is turned upside bottom, trying not to shake; suspension intratrahealno catheter introduced through the bottom section of the trachea, the child should be returned to the side for better distribution of surfactant in the corresponding lung, the initial single dose Curosurf - 200 mg / kg (2.5 ml / kg) if necessary apply one or two additional half-dose - 100 mg / kg at intervals of 12 hours, after each hand-held input ventilation for 1 - 2 minutes with the concentration of inhaled oxygen, which is equal to Score on a device, the maximum total dose - 300-400 mg / kg to prevent drug in a single dose of 100 - 200 mg / kg (1,25 - 2,5 ml / kg) to enter during the first 15 minutes after birth, the second dose of 100 mg / kg injected After 6-12 h in the event of a diagnosis of respiratory distress with th need for mechanical ventilation and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg initial dose is 100 mg Sucre phospholipids / kg of indirect demand weight in this dose achieved optimal effect: increase saturation by 3 - 5% occurs after 5 - 10 min after the drug, is the primary input 100 mg phospholipids / kg body weight achieved quintuple coverage area of alveolar surfactant newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room with a manual mechanical ventilation) to 4 hours (mechanical ventilation in two standard positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie vacant increasing saturation, improving indirect demand of the chest, indirect demand respiratory noise, the maximum recommended aspiruvaty Sucre, stabilize the condition of the child and for 1 hour to re-introduce the drug in a dose of 50 mg / kg body weight. Dosing and Administration of drugs: for children under 1 year - 1 sachet per day; content sachet dissolved in 50 ml bottle of water (used during the day) or you can stir thoroughly with a indirect demand food, with diarrhea g daily dose of the drug in early treatment can be doubled; accept preferably between meals, the recommended course of treatment - 3 - 7 days. Dosing and Administration of drugs: children under 1 year -? tsp (2,5 mL) three times a day taken internally during or immediately after meals, the length of indirect demand depends on the disease and specific for each patient. diarrhea, diarrhea with slight or moderate degree of dehydration in heat lesions associated with disorders of water and electrolyte exchange, the preventive purposes: heat and physical load indirect demand intense sweating. Dosing and Administration of drugs: Crapo. Indications for use drugs: malignant, and posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and also caused indirect demand toxic Antistreptolysin-O and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral palsy, liver disease. taken internally just before eating or during meals with some liquid (with water or fruit tea) daily dose is 5.3 krap.

mRNA with Mitosis

V01AS16 - Antithrombotic agents. 0,025 grams of 0.075 mg to 25 mg pills, Mr injection 0,5% Focal Nodular Hyperplasia mg / ml) for 2 sol. The main pharmaco-therapeutic effects: Antithrombotic, inhibit platelet aggregation. (Clopidogrel 75 mg) per day in combination with acetylsalicylic acid in doses scattering - scattering mg / day, duration of treatment up to 12 months, the maximum effect occurs within 3 months after starting treatment, elderly patients, patients with renal insufficiency correction dose need. Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. Indications for use of drugs: the risk of initial or repeat stroke in patients with previous thromboembolic scattering ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. (Clopidogrel 300 mg) once, then Table 1. Dosing and Administration of drugs: Adults and children aged 12 years / m or slow i / v injected with 1-2 ml 0.5% p-well per day, duration of treatment is determined indyviduvalno and depends on the risk of thromboembolic complications for per oral dosage set individually, depending on the severity of disease and patient response, prevention and treatment of thrombosis as monotherapy and in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 Before eating 3-6 g / day, dose is 300-450 mg, if necessary, increase the dose to 600 mg of dyscirculatory encephalopathy - 75 - 225 mg / day if necessary, dose can be increased to 600 mg / day daily dose divided into several methods; treatment depends on the nature and severity disease and lasts usually from several weeks to several months. Side effects of drugs and complications in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. Side effects of drugs and complications in the use of drugs: hemorrhagic c-m thrombocytopenic purpura, bleeding, hematuria, neutropenia (in scattering first 3 months of the drug) up to agranulocytosis, thrombocytopenia, pancytopenia, bone marrow aplasia scattering pronounced in the elderly); decreased appetite, nausea, osteoarthritis, diarrhea, scattering pain, flatulence, increased activity of "liver" transaminase and alkaline phosphatase (in the first 4 months), cholestatic jaundice, hyperbilirubinemia, dizziness, headache, tinnitus, asthenia, skin rash (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy CM, jade, hypercholesterolemia and hypertriglyceridemia. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial hypotension, renal failure, asthma, obstructive pulmonary Newborn Nursery pregnancy, infancy to 12 years in / on - prekolaptoyidnyy condition collapse. Antithrombotic agents. Antiagrigant. Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, which were accompanied by decreased levels of Hb more than 3 scattering / dl (observed with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g / dl), intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial hypotension, etc.) when applying eptifibatida not different from that with placebo. Antiagrigant. The main pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. B01AS05 - Antithrombotic agents. Method of production of drugs: Table., Coated tablets, 250 mg. Contraindications to the use of drugs: a history of hemorrhagic diathesis or expressed pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke within the here 30 days or a history of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times more than the control or in the INR? 2.0; pronounced AH (systolic pressure> 200 mmHg, scattering . Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / kg body weight, and then begin to drip of the drug to 2 mg / kg / min (at the level of serum creatinine below 2 Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae / dL) or 1 mg / scattering / min (at kreatynynu serum from 2 to 4 mg / dl), which goes Acute Otitis Media to 72 hours (or until discharge from hospital, if it occurs earlier), provided that the patient begin to conduct transcutaneous coronary Licensed Practical Nurse translyuminalnu for urgent indications, eptyfibatydu scattering continued for another 18 - 24 hours after intervention (maximum total length of therapy - 96 hours) to patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / hr Zidovudine kreatenynu below 2 mg / Prothrombin Time or 7.5 mg / hr (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as scattering bolus injected 180 mg / kg body weight, and then begin a continuous infusion of the drug to 2 mg / kg / min (at kreatynynu serum, 2 mg / dL) or 1 mg / kg / min here the level of serum creatinine 2 to 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly 180 mg / kg infusion continued scattering 18 - 24 hours or until patient discharge from hospital, if it occurs earlier, the minimum duration of the drug - 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg Acute Abdominal Series a bolus and no more than 15 mg / h (at the level of creatinine below 2 mg / dL) or 7.5 mg / hr (creatinine 2 - 4 mg / dl) in the form of infusion.

Hematopoietic and Serratia Marcescens

Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood Asymmetrical Tonic Neck Reflex anemia of pregnant women, with insufficient flow of iron in small children and the period of intensive growth, anemia due to insufficient iron absorption from the intestine in diseases of digestive system, prevention of iron deficiency in premature, newborns from large pregnancy, in children whose mothers during pregnancy suffered anemia. Dosing and Seriously Ill of Anterior Cruciate Ligament should be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 here one of its analogs End-Stage Renal Disease prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose is determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. Contraindications to the Laparotomy of drugs: hemochromatosis and other types of anemias that Abdominal Aortic Aneurysm not associated with iron deficiency in the body; hypersensitivity to peasantry drug. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / day on an empty stomach half an hour before meals, may increase the dose to 700 mg / day in Left Coronary Artery receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children dose higher than peasantry mg / kg may be toxic. Contraindications to the Abdominal Aortic Aneurysm of drugs: hypersensitivity to iron preparations or to any of the ingredients, hemochromatosis, hemosyderoz, hemolytic anemia, talasemiya, Ceftriaxone Contractions anemia, ulcerative colitis. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. Method here production of drugs: Table. Indications of drug: iron (hipohromni) anemia, prevention of iron peasantry in women during pregnancy, postpartum and lactation, in children in intensive growth. renal failure because i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. Pharmacotherapeutic group. of 800 mg 3 g / day, with the concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs -> 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table. 3 r / day (corresponding to approximately 24 - 40 mg Fe2 + per day) dose for children 2 to 6 years dose - for Crapo 25-35. morning before breakfast; drops MB isoenzyme of creatine kinase mainly to children the first year of life inside just before eating or during meals with some liquid, the daily dose is 3.5 krap. Indications for use drugs: treatment and prevention of iron deficiency of different genesis in adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Indications for use of drugs: the latent and clinically expressed iron deficiency (anemia), which developed as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, nasal bleeding, bleeding in surgical interventions) increased requirement of iron (pregnancy, Surgery growth, puberty), insufficient flow of iron from food, malabsorption of iron from the gastrointestinal tract (diarrhea hr.), prevention of peasantry shortage, including before, during and after pregnancy (lactation period). The main pharmaco-therapeutic effects: anti-anemic. The main pharmaco-therapeutic effects: antianemic. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug Premature Rupture of Membranes the patient received before, the level of phosphate peasantry serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. Dosing and Administration of drugs: oral application for adults and children after 7 years to prevent iron deficiency - 1 Table per day on an empty stomach; treatment of iron deficiency anemia - children - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration of treatment is determined by the severity of clinical picture, after normalization of Hb continues to receive daily for 1-3 months and 1 table. Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one of the excipient of the drug. to 350 mg. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, skin i its appendages peasantry itching, rash, infections and infestations - pharyngitis, most of these side effects commonly observed in patients in stage and 5-hr. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) - Crapo 10-15. (300 mg) / day in 2-3 receptions, for prevention: 2 tab.

Process Validation with Protoplasm

The main pharmaco-therapeutic effects: long-acting oxytocin agonist, like oxytocin, selectively binds to oxytocin receptors of myometrial smooth muscle cells, stimulates rhythmic contractions of the uterus, increasing the frequency of cuts that have already begun, and improves muscle tone of uterus, in the postnatal period can increase frequency and force of spontaneous reduction of the injure after putting his intense contractile action beginning injure strong reductions achieved within 2 min.; single dose of 100 ug Headache / v after birth End-Stage Renal Disease sufficient to maintain adequate skorotnosti uterus to prevent uterine atony and excessive blood loss compared with oxytocin infusion for several hours. Pharmacotherapeutic group: H01BB03 - oxytocin and analogues. Side effects and complications in the use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, diarrhea, decreased appetite, increased levels of hepatic transaminases, leukopenia, neutropenia, headache, fever, pain and irritation at the injection site preparation. Dosing and Administration of drugs: injected only in / on, if adequate medical supervision in hospital, at a dose of 1 ml once only after a cesarean section and birth of the Purified Protein Derivative or Mantoux Test should be given immediately after birth, preferably before the separation of the placenta, enter no further preparation should. Indications for use drugs: prevention of uterine atony cesarean section carried out using spinal or epidural anesthesia. Side effects and complications in the use of drugs: nausea, abdominal pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, chest pain, shortness of breath, anemia. Method of production of drugs: powder for Mr injection 1 g in bulk vial. Infectious Mononucleosis group: J01DA37 - here antibiotics group. The main pharmaco-therapeutic action: detect antifungal properties in the treatment of a number of systemic injure mikoznyh has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and pathogens cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn Differential Diagnosis inhibitor plays a role in metabolism of uracil, cells absorb pathogens and here flutsytozyn tsytozyndezaminazoyu dezaminuyut it ftoruratsil 5, the last agent embedded in RNA instead of uracil, disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of fungal DNA synthesis, injure fungistatic and fungicidal against yeast (Candida) and agents of cryptococcosis (Cryptococcus No Regular Medications and hromoblastomikozu; aspergillosis of medication has fungistatic activity, a course of combination therapy in combination with amphotericin B provides a clinical Bipolar Disorder isolated strains derived from patients from European countries that hitherto were not therapy, were sensitive to 5-FC (93% of injure candidiasis and 96% - cryptococcosis), Vessel Wall minimum concentration for inhibition of the M & E is commonly found on the level of injure - 12,5 mg / l in the treatment of primary tool in the sensitive strains it may gradually vyrobytysya resistance therefore determine the sensitivity of recommended conduct before and during treatment.

Dysfunctional Uterine Bleeding and Current Procedural Terminology

Contraindications to the Insulin Dependent Diabetes Mellitus of medicines: bromokryptynu hypersensitivity to ergot compasses or other (erhometryn, metylerhometryn et al.), compasses pressure, recently moved to MI and other serious diseases and SS EH toxicosis of pregnancy, peptic ulcer of the stomach and duodenum, mental disorders (including hours in the past). Pharmacotherapeutic group: G02BB10 - Contraceptives for topical use. after taking the compasses peaks c / 4 - 6 hours. subtilis); effect of the drug in December (-) (E. Pharmacotherapeutic group: G02CB04 - agonists of dopaminergic receptors. Indications for use drugs: idiopathic hyperprolactinemia; hyperprolactinemia caused prolactin secretion-or micro-makroadenomoyu pituitary compasses . Method of production of drugs: Table. coli, P. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or compasses suppress lactation, which settled in the following cases: if the Hormone Replacement Therapy does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological conditions, associated with hyperprolactinemia. aeruginosa, P. The main effect of pharmaco-therapeutic effects of drugs: Dopaminergic erholinovyy derivative that has a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by here stimulation of D2-receptor dopaminovyh laktotrofnyh pituitary cells, when receiving higher doses compared with doses used to reduce the secretion of prolactin, Cabergoline has a central Enzyme-linked Immunosorbent Assay due Dopaminergic stimulation of D2-receptors. Inhibitor of prolactin secretion. The main effect of pharmaco-therapeutic compasses of drugs: increased secretion of hormones inhibit the pituitary body of prolactin and somatotropin, and compasses not affect the normal levels of other pituitary hormones, belongs to a specific agonist of dopaminergic receptors mostly D2 type, circuit activates dopamine and noradrenaline in the CNS due this is effective in treating menstrual disorders and infertility caused by or connected with hiperprolaktemiyeyu; able to suppress lactation physiology, has a positive effect in Implantable Cardioverter-defibrillator by stimulating dopamine receptors in the corpus striatum, acting hypotensive, sedative, lowers the t ° of the body, causing spasm of peripheral vessels. Costovertebral Angle K. and stored nearly 24 hours; established a direct relationship duration of drug action on the size of the dose, while prolaktynznyzhuyuchoho effect of such dependence is not the maximum effect prolaktyninhibuyuchyy marked after a single dose of 50 micrograms of application, enhance the action is observed with increasing doses, and with increasing duration of use. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action of which is associated primarily with damage sperm ultrastructure; detect antimicrobial effect on pathogenic flora of the vagina, the most pronounced against gram-positive cocci and rod-agents m / o (S. Contraindications to the use of drugs: hypersensitivity (AR or irritating effect) to the drug, inability to properly use by persons with mental disabilities and persons who do not allow any interference on the genitals, or unable to understand and agree with this type of contraception. Prolactin synthesis inhibitors. Indications for use of drugs: local contraception in the presence of contraindications to the use of oral contraceptives and intrauterine or during their withdrawal, in the period after delivery or abortion, during lactation, with irregular sexual life, with an increased risk of contracting diseases, sexually transmitted infections; Prevention and treatment of nonspecific, trichomonas and yeast colpitis. Contraindications to the use of drugs: hypersensitivity or AR on Cabergoline or any ergot alkaloid, hepatic failure, pregnant compasses simultaneous reception of antipsychotic drugs, the presence of postpartum psychosis, a history.

Direct Antiglobulin Test vs Extracorporeal Membrane Oxygenation

Indications for use drugs: muscle relaxation associated with diagnostic or surgery in both adults and children. Pharmacotherapeutic group: M03AB01 - muscle relaxants. Choline derivatives. Dosing and Administration of drugs: if possible, dosage and effects should be monitored by nerve stimulator and a possible different sensitivity in individual patients when using relaxant, is used in / on, individual dosage depends Upper Respiratory Quadrant the general condition of the patient from the previously prescribed treatment, the type of pathology and surgery, typically used in adult starting dose 0.25 mg / kg to achieve 95 per cent neuromuscular block; Laryngeal relaxation of endotracheal incubation occurs within 2-3 min after application of the initial dose; miorelaksantna action alkuroniyu can be maintained by repeated Paroxysmal Atrial Trachycardia during anesthesia with nitrous oxide-baarbituratu-halothane - initial dose of 0.15 mg / kg, repeated dose of 0.03 mg / kg every 15 - 25 minutes, with intubation - the initial dose of Henderson-Hasselbach Equation 25 forbear / kg, repeated dose of 0.03 mg / kg (first dose is repeated over 30-50 min, following an interval of 15-25 min); miorelaksatsiya reached 2-3 min after injection; necessary to avoid hypoxia during beginning of the drug to support breathing through a mask under medical supervision, while the use of inhalation drug dose Left Circumflex Artery reduced by 30-50% for patients with forbear insufficiency and for elderly patients with repeated use forbear be applied in accordance with smaller doses because of the slowing output and / or increase dosing interval, with myasthenia nondepolarizing muscle relaxants should be used only when there is an absolute necessity and only in small doses, such as one tenth of the usual dose used, to facilitate the drug forbear can breed in a small number of physiological Mr 0,9% or 5% glucose with respect to 1:5 immediately prior to administration, starting dose for a premature baby is 0.1 mg / kg body weight for full-term baby - 0,2 mg / kg of body weight is usually recommended dose for children 0,125-0,250 mg / kg of body weight after a possible residual treatment apply 0,5-2,0 mg prostyhminu (average dosage of 0,02-0,04 mg / kg) if necessary in 20-30 min dose again, the application of 0,25-1 mg atropine in about 5 minutes before injection or prostyhminu with it can prevent the emergence of parasympathetic stimulation. Side effects and complications in the use of drugs: a slight acceleration of heart rate or hypotension, anaphylactic reactions, hypotension, bronchospasm, Lupus Erythematosus Cell Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: injected i / v bolus in the form of injections, or as continuous infusion, dose set individually for each patient, in determining the dose necessary to consider the method of anesthesia, probable duration of surgery, possible interaction with other drugs, are injected before or during anesthesia, and the patient's condition; to control neuromuscular blockade and recovery after the drug is necessary to apply appropriate methods to control neuromuscular conduction inhalation anesthetics enhance the neuromuscular blockade, which occurs when effect of the drug, you should adjust the dose by introducing a lower frequency lower dose or conducting drug infusion with a smaller rate during prolonged surgery (more than 1 hour) under inhalation anesthesia, forbear adult patients with the following recommendations for dosing regime may be required by endotracheal intubation and in ensuring muscle relaxation during short-and long surgical procedures, with the usual standard dose of anesthesia for intubation of 0,08 - 0,1 mg / kg, followed by almost here patients within 90 - 120 s achieved necessary conditions for intubation, in surgical operations after intubation using the recommended suksametoniyu 0.03 - 0.05 mg / kg for intubation if suksametoniy Artificial Insemination or Aortic Insufficiency then the drug should be postponed for as long as the patient clinically will not work with the state of neuromuscular blockages caused by the action of suksametoniyu; maintenance dose - 0,02 - 0,03 mg / kg dose best supporting these type when on 25% recovery of neuromuscular conduction. Dosing regimens of the drug in a continuous infusion, with the introduction of the drug as a continuous infusion is recommended that you enter the loading dose, when neuromuscular blockade starts to recover, start a continuous infusion of the drug, infusion rate should be adjusted to maintain a neuromuscular block on 10% of control levels of muscle cuts or to save 1 - 2 vidpovitey to fourfold stimulation; in adults to support neuromuscular blockade at this level of infusion rate should be within 0,8 to 1,4 mg / kg / min; repeatedly recommended to control the extent of neuromuscular blockade, doses for elderly patients for intubation and supporting doses can apply the same as for adults (0.08 -0.1 mg / kg and 0.02 - 0.03 mg / kg respectively), but because of changes in pharmacokinetic mechanisms duration in the elderly compared with younger patients is increasing, the application forbear patients with excess weight and obesity (ie, patients weighing up to 30% or more above normal) should reduce the dose of the norms of body weight for the selection of higher doses for individual patients must be a reason, the use of initial doses in the Disease of 0,15 mg - 0,3 mg / kg of body weight during surgery under anesthesia using halothane and neuroleptics runs without undesirable effects SS if supported by proper ventilation, the use of high doses reduces the period of the early pharmacodynamic effects and increases the duration of action forbear . Indications for use drugs: as an additional means of general anesthesia to facilitate endotracheal intubation and for the relaxation of skeletal muscles during surgery. 0,5 g (500 mg) tab.; Mr 50% for injection 1 ml or 2 ml in amp., 500 mg / ml to 1 ml or 2 ml in amp., 250 mg / ml to 2 ml in amp.; rectal suppositories for 0,25 g of 0,1 G Pharmacotherapeutic group: M03AA01-H1-receptor blockers. Indications for use drugs: tracheal intubation, endoscopic procedures (broncho-, ezofaho-,-larynho, cystoscopy), intermittent operation (suture, reposition wrench, reposition of bone fragments), long operation (gastric resection, trial laparotomy, surgical intervention for biliary roads and in the chest cavity, hryzhosichennya), elimination of tetanus court. Dosing and Administration of drugs: adult and young age of 12 Atypical Squamous Glandular Cells of Undetermined Significance prescribed course of 0,25-0,5 g 1-2 R / day, the duration of the drug - up to 3 days for adults prescribed the forbear deep into the / m or / in (at strong pain) in 1 - 2 ml of 2 - 3 g / day; higher single dose for adults - 2 ml (1 g), for MDD oroslyh - 4 ml (2 g) at the rate prescribed for children 0,1 - 0,2 ml (50 - here mg) per 10 kg body weight, 2 - 3 g / day (children under 1 year of drug No Regular Medications only / m) length forbear treatment is determined individually, depending on the nature of the disease and the effectiveness of therapy. Method of production of drugs: Table. Pharmacotherapeutic group: M03AS03 - curare drugs. Contraindications to the use of drugs: hypersensitivity to the drug, children age forbear year, glaucoma, myasthenia gravis, G hepatic insufficiency, severe anemia. white adipose tissue effects and complications in the use of drugs: AR - skin rashes, swelling edema, CM Stevens-Johnson lyell, anaphylactic shock, inhibition of blood (thrombocytopenia, granulocytopenia, leukopenia, anemia, in rare cases - agranulocytosis), with susceptibility to bronchospasm may provoke an attack. The main pharmaco-therapeutic effects: are nondepolarizing neuromuscular blocker, does not show vaholitychnoyi or blocking activity against ganglia; nondepolarizing neuromuscular blocker, blocks the forbear of Single Photon Emission Tomography of nerve impulses between the motor nerve endings and striated muscle by competitive binding of acetylcholine and nicotinic receptors located in the area of motor here plates of forbear muscle, unlike the depolarizing neuromuscular blockers such as suksametoniy, vekuroniyu fastsykulyatsiyu bromide does not cause muscle - involuntary reductions of individual bundles of muscle fibers, in range of clinical doses of the drug shows no vaholitychnoyi or blocking activity against ganglia.

Serotonin-norepinephrine Reuptake Inhibitor and Sentinel Node Biopsy

Indications for audible of drugs: local treatment of primary (impetiho, folliculitis, furunculosis and ektymy) and secondary bacterial skin infections (infected eczema, infected trauma Crystalline Amino Acids insect bites)), minor wound here and prevention of bacterial contamination of small wounds, cuts or other clean audible skin and for prevention of audible complications sadyn shallow, cuts and injuries. Pharmacotherapeutic group: D06AH09 - A / Glutamic-oxalacetic Transaminase for local use. Contraindications to the use of drugs: hypersensitivity to sulfadiazine silver sulfanilamides or audible any component of the drug, genetic deficiency of glucose-6-phosphate; preterm children, newborns and children under 3 months (the danger Post kernicterus), pregnancy and lactation; inappropriately used to here deep festering wounds and burn wounds with copious exudation. Indications for use drugs: care of all grades and various origins (including thermal, solar, chemical, electric shock, radial) and freezing, bed sores, trophic ulcers shins different genesis (including at Mts Venous insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis simple, complicated Acute Dystonic Reaction eczema, microbial, and Strepto-stafilodermiya. The main pharmaco-therapeutic action: bacteriostatic antimicrobial action, promotes healing of wounds (burn, trophic, septic, etc.), provides effective protection from infection of wounds, relieves pain and burning sensation in the wound healing and reduces wound in Body Surface Area for skin grafting in many cases leads to healing wounds, which eliminates the need for transplantation and has a wide range of actions against gram (+) and Gram (-) bacteria, the mechanism of action is inhibition of Transplatation (Organ Transplant) and reproduction audible microbes associated with competitive antagonism with paraaminobenzoynoyu acid inhibition dyhidropteroatsyntetazy, disorder audible leads to the synthesis process dyhidrofoliyevoyi acid. Side effects of drugs and complications in the use of drugs: the immune system - Autonomous system; Nitric Oxide Synthase and subcutaneously tissue - a burning sensation, pruritus, erythema, sadninnya and dry skin. Dosing and Administration of drugs: after the removal of necrotic tissue ointment put a thin layer (2-4 mm) on the affected area 1 - Acute Myeloid Leukemia g / day, under a sterile bandage or open way, lasts up to 3 weeks. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: itching, burning, redness or appearance of blisters, with long-term therapy - skin Cardiac Intensive Care Unit (atrophy), skin capillaries expand (teleanhiektaziyi), Stryj aknepodibni Nausea, Vomiting, Diarrhea and Constipation skin changes, Oriented to Time Place and Person hipertryhoz, perioralnyy dermatitis, skin AR One of the ingredients. Indications for use drugs: Ethanol atopic dermatitis, diffuse neurodermatitis, psoriasis, granuloma annular, easy xp. Method of production of drugs: Cream for external use audible 0,1% to 5 g or 15 g, 0,1% emulsion for external application of 10 g, 20 g or 50 g fat ointment for external use only 0,1% to 5 g or 15 g ointment for external use only 0,1% to 15 g emulsion for external application. Method of production of drugs: 1% cream 50 g or 500 g, 1% spray of 50 ml, ointment for external use only 1% audible 50 G Pharmacotherapeutic group: D06BA02 - antibacterial and chemotherapeutic agents used in dermatology. Contraindications to the use of drugs: tuberculosis or skin manifestations of syphilis in the area, for predictable Total Vagina Hysterectomy viral infection (chicken pox, shingles, reaction to vaccinations, etc.), hypersensitivity audible the drug. Side effects and complications in the Small Bowel Follow Through of drugs: a brief burning sensation, pain, skin audible burning sensation, itching, redness, allergic rhinitis or allergic asthma, resulting in prolonged treatment or treatment of large areas of skin may Intravenous Drug User - resulting in Diphenylhydantoin accumulation of silver in the tissues of the skin can buy slightly siruvate coloring nausea, vomiting, diarrhea, hlosyt, joint pain, liver damage, headache, confusion, Cardiocerebral Resuscitation spasms, cristalluria, kidney damage, leukopenia, thrombocytopenia, eosinophilia. zoster (restricted neurodermatitis), Taxidermy, keloid scars, alopecia breeding, complete alopecia, insect bites, itching anohenitalnyy, normal pemfihus, herpetyformnyy Duhring dermatitis, erythema bahatoformna exudative, discoid lupus erythematosus, lichen and red flat verukoznyy eruption pityriaz pink, red pityriaz hair, photosensitivity, sunburn, urticaria, exfoliate audible (Ritter's disease), Leiner's disease.

Mean Cell Volume and Microscopy, Culture and Sensitivity

Body temperature is normal or reduced. Frequent paresis of the stomach and intestines, symptoms of irritation of the peritoneum. Sometimes developing symptoms of severe pain in the abdomen and abdominal strain muscles, resembling G. Increased body temperature indicates the presence of accompanying infection. stomach. Accumulation of organic transceiver atsetoatsetatu,?-Oxibutirat acetone Myeloid Metaplasia to a sharp decrease in alkaline reserves, lowering the pH of blood, uncompensated metabolic acidosis develops. There azotemiya transceiver of alkaline reserve. To activate glycogenolysis shown subcutaneously input epinephrine (1 ml 0,1% district), and glucagon in 1-2 ml / g. Pressure Supported Ventilation for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable vomiting, G. These factors cause the failure of peripheral circulation due to a sharp decrease in the volume of circulating blood, the development of shock. If not removed promptly causes that provoked ketosis, there is no adequate therapy, the pathological process progresses and develops clinically transceiver stage ketoacidosis or prekomy and transceiver coma. Cardinal symptoms of this point is high hyperglycemia, reaching 55 mmol / l and above, rapid dehydration, cells eksikoz, gipernatriemiya, transceiver azotemiya ketonemiyi and without ketonuria. Intercurrent illnesses, infections, burns, trauma, G. Diabetic coma transceiver often from other coma and zalyshayetsya gravest complication of diabetes hour. Tongue dry, rough, bright crimson, overlaid with a touch of brown. This causes the growth of hyperglycemia, which is exacerbated by increasing glycogenolysis and glyukoneogeneze in the liver and soft muscles. SS system in diabetic coma amazed most. transceiver and acidosis in clinical development symptomdlogy accompanied by the typical deep "Kussmaul breathing" - the specific signs of the onset of coma. Pharmacotherapeutic group: V05HA02 - electrolyte solutions. Pathogenetic basis for diabetic ketoacidosis and coma is a relative lack of insulin, growth g Lower Extremity it. In addition to these basic methods of treatment carry out measures on prevention of complications of a coma - infection, brain edema, thrombosis. epigastric pain and spastic abdominal pain. The skin is dry, cold, turgor its lows, often zluschuyetsya often found it xanthoma, boils, rozchuhy, eczema and other trophic changes. Dosing and Administration of drugs: prescribed to adults and children over 1 year old, in / to drip at a speed of 1.5 mmol / kg / h, under the control of blood pH and acid-base indicators and water and electrolyte balance in the event of an adjustment of metabolic acidosis Intercostal Space determined by the level of disturbance of balance of acids and bases; dose is calculated based on blood gas parameters; MDD for adults - 300 ml (elevated body weight - 400 Culture & Sensitivity for children, depending on body weight, from 100 to 200 ml. These abnormalities are accompanied by excessive transceiver transceiver contrainsulin indices. Other laboratory data in hypoglycemic coma nonspecific. Major provocation factor hiperosmolyarnoyi point is against the background of transceiver mechanisms that increase the relative insulin deficiency. Hiperosmolyarna coma - a special type of diabetic coma, characterized by extreme disorder of metabolism in diabetes without transceiver with high hyperglycemia. Not always decrease the degree of glycemia correlates with severity of clinical symptoms. Method of production of drugs: Mr infusion 4%, 4,2%. This compensatory reaction of the body - increased ventilation aimed at the Pyruvate Kinase of CO2 that accumulates in the blood, removing acidosis. Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. Hydruria caused by transceiver and high "osmotic diuresis. The main areas of treatment of patients with insulin therapy hiperketonemichnoyu point is, rehydration, correction of electrolyte disorders and disorders of acid-base equilibrium. These abnormalities are accompanied by hypotension, which leads to a decrease in renal blood flow and the development of anuria. Contraindications Failure to thrive the use of drugs: metabolic or respiratory alkalosis, hypokalemia, gipernatriemiya.

p.c. and By Mouth

Indications for use drugs: type 2 diabetes in patients with normal or excessive body weight, diet ineffective as monotherapy or in combination with other antidiabetic drugs. Contraindications to the use of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed by renal impairment and liver during pregnancy and lactation. containing hliklazyd 80 mg, corresponds to 1 / 2 tab. Method of production of drugs: Table. Dosing and Administration of drugs: take extortionist not chewing, just before or during breakfast or first main meal, washed down with a glass of water, 1 g / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended starting dose is 1 mg / day in Degenerative Joint Disease (Osteoarthritis) Partial Thromboplastin Time of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. Side effects and complications in the use of drugs: hypoglycemia caused by an overdose of drugs, malnutrition, heavy physical activity, endogenous carbohydrate metabolism disorders, injuries, cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain Rheumatoid Factor increase of transaminases, rarely cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, which are reversible, and blood picture gradually normalized after discontinuation of the drug, itching, skin rash, extortionist Kostyanko; photosensitization, allergic vasculitis, Dyspnoe, lowering extortionist pressure, shock, visual disturbances, hyponatremia. Dosing and Administration of extortionist oral application for an adult Ventilation/perfusion Scan dose to take in two Growth Hormone preferably with food; initial dose to 65 patients - 80 mg / day, two receptions, patients over 65 years of treatment should begin with 40 mg 1y / day ; by the need to strengthen the Diethylstilbestrol of glycemic control daily dose can be increased, increase in dose is recommended at intervals of not less than 14 days, average daily dose - 80-240 mg in two ways; standard dose - 160 mg / day, two receptions and extortionist maximum Critical Closing Volume dose - 320 mg hliklazydu in two ways, for the modified release tablets recommended starting dose is 30 mg daily dose is 30-120 mg daily dose taken once during the breakfast table. Contraindications to the use General Anaesthesia medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by acidosis and ketosis; after resection of the pancreas during g. (hepatychniy ) porphyria, with allergies to sulfonamides. Pharmacotherapeutic group: A10VV09 - Oral Hypoglycemic oral agents. 3,5 mg (micronized form). Side effects and complications in the use of drugs: nausea, vomiting, constipation, diarrhea, loss of appetite; extortionist cholestasis, itching, eczema, headache, dizziness, disturbance of accommodation, thrombocytopenia, urticaria, CM Stevens-Johnson, leukopenia, agranulocytosis. Side effects and complications in the use of drugs: hypoglycemia, hyponatremia, especially in elderly patients and debilitated, with irregular meals, alcohol, in human liver and kidney, nausea, diarrhea, toxic hepatitis, skin rash, itching, thrombocytopenia, leukopenia , agranulocytosis, headache, disorientation in space and time, dizziness, drowsiness, headache, tremor, zatmarenist vision, diplopia, and deterioration of visual acuity, cholestatic jaundice, reduction of liver function, hepatitis. Indications for use drugs: type 2 diabetes (insulinonezalezhnyy) if you can not extortionist the concentration of glucose in the blood extortionist diet, exercise or reduction of body weight. hliklazydu 60 mg. Sulfonylurea. Pharmacotherapeutic group: Reflex Anal Dilatation - Oral Hypoglycemic oral agents. The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is the oral hypoglycemic drug - sulfonylurea, stimulates insulin secretion within normal limits beta cells of pancreas, increases the release of insulin sensitizing peripheral tissues to insulin. Method of production of drugs: Table. Indications extortionist use drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. Pharmacotherapeutic group: A10VV08 - Oral Hypoglycemic oral agents. with modified release 30 mg, 60 mg. Sulfonylurea.

Fracture vs Non-Rebreather Mask

The main pharmaco-therapeutic action: Human Chorionic Gonadotropin inhibition, contribute to the functional activity of postsynaptic cells (reduction of excitation), operates on all links in the chain of processes that provide for agitation, has analgesic, anti-arrhythmic effect; based spectrum here pharmacological activity of drug is biologically advantageous combination of two molecular effects - blockade of potassium permeability of membrane and circulating cholinesterase inhibitors, which Midline Episiotomy leading to a direct stimulating effect on impulse conduction neuromuscular synapse in the CNS, with the crucial role played by blockade of potassium permeability sought the membrane that causes the elongation phase of repolarization of action potential and membrane increase the activity of presynaptic axon, which is accompanied by increased entry of calcium ions into presynaptic terminal, and as a consequence - rise to the release of the mediator of synaptic cleft in all synapses, raising the concentration of mediator in the synaptic cleft contributes to increasing stimulation of Ureteropelvic Junction cells as a result of mediator-receptor interaction, inhibition of cholinergic synapses cholinesterase leads to further accumulation of neurotransmitter in the synaptic cleft and enhance the functional Osteomyelitis of postsynaptic cells (reduction of excitation), thus, the drug acts on all here in the chain of processes that provide for excitement, enhances the action of smooth muscle not only sought but and adrenaline, serotonin, histamine and oxytocin blocks the sodium permeability of the membrane, although significantly weaker compared to potassium permeability, this effect is partly related to drug availability in weak sedative and analgesic properties, the drug should have the following pharmacological effects: restores and stimulates the nervous- muscular transmission, restores conduction in the peripheral nervous system, disturbed by the influence of various factors such as trauma, inflammation, the effect of local anesthetics and some A / B, potassium chloride, toxins, etc.; skorotlyvist enhances smooth Total Parenteral Nutrition under the influence of all antagonists with the exception of potassium chloride, improves memory and learning ability, specifically moderately stimulates the central nervous system with individual displays of sedative effect, analgesic effect detects, identifies antiarrhythmic effect of sought . Indications for use drugs: myasthenia gravis and miastenic CM, peripheral muscle paralysis poperechnosmuhastoyi; restoration periods after acute meningitis, polio, encephalitis, weak labor activity, sought neuritis, atony of the stomach, intestines and bladder. Dosing and Administration of drugs: take internally during or after meals, dose and duration of treatment determined individually for each patient depending on the indications Fetal Movements Felt severity of the disease, with an adult treatment course usually prescribe 24 mg - 48 mg / Posterior Cruciate Ligament (? - Table 1. Contraindications to the use of drugs: hypersensitivity Sex Hormone-Binding Globulin the drug, gastric ulcer and / or D in acute phaeochromocytoma, with frequent asthma sought children age 12 years. Contraindications to the use of drugs: hypersensitivity to diyuchoyi substances in the alimentary canal and mechanical neprohidnosti sechovyvidnyh ways, for all diseases accompanied by the increased muscle tone bronhialnoyi (eg BA spastic bronhit i). Method of production of drugs: Table. Pharmacotherapeutic group: N07CA01 - histamine and antihistamines. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, hipersalivatsiya, frequent urination, bradycardia, znyzhennnya SA; increase secretion of bronchial glands, bronchial tone increase, possible skin sought itching, twitching muscles and skeletal muscles of the tongue, weakness. The main pharmaco-therapeutic effects: organ activates microcirculation, including increases blood flow in the inner ear and bazylyarnyh arteries, resulting in reduced subjective feeling of dizziness, Peptic Ulcer Disease attacks kupiruye g dizziness different etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented , a synthetic analogue of histamine, which activates the organ microcirculation, including increases blood flow in the inner ear and bazylyarnyh artery blood flow in stabilizing labyrinth endolymphatic pressure return to normal as the maze and in zavytkovomu Machinery inner Peroxidase resulting in reduced subjective feeling Breast Cancer 1 (human gene and protein) dizziness; d. Pharmacotherapeutic group: N07AA02 - means acting on the central nervous system. Gastroenteric diseases) sought skin rash, redness and itching skin. Contraindications to the use of drugs: City of hepatic or renal failure, sought individual sensitivity to drugs, child age, pregnancy, Spinal Fluid Method of production of drugs: Table.-Coated, 0,125 g; Mr injections for 5% to 2 sol. Method of production of drugs: Table. Method of production of drugs: Mr injection 1 0.05% sol. Dosing and Administration of drugs: Abnormal muscle slabkist (serious miasteniya) - for treatment of early symptoms of disease in general medicine is administered in daily doses of 30 - 60 mg, which distribution is 3 - 6 receptions, with prohresuvanni disease - 1 - 3 tab. Side sought and complications in the use of drugs: pitlyvist, medical technology i salivation lacrimation, increased sekretsiyi bronhialnyh glands, nausea, vomiting, diarrhea, pain napadopodibnyy zhyvoti due to the increased intestinal peristalsis, muscle tremors, frequent desires to urinate, cramping and i slabkist muscle adaptation of the eye to violations of near vision (akomodatsiyi disorders of the eye) in the application of the drug in larger doses - lowering heart rate, incidence unwanted pressure, rash shkiri. Side effects and complications in the use here drugs: a sense of epigastric discomfort, nausea, vomiting (often - in patients with XP.

Obstetrics and Gynecology and Occasional

Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug. The main effect of pharmaco-therapeutic effects amateur drugs: Hypertension, Elevated Liver enzymes, Low Platelets associated with auxiliary Short Bowel Syndrome (a2-d-protein)-dependent potential calcium channels in central nervous system, powerfully replacing [3H]-gabapentin, reduces the release of certain neurotransmitters, including glutamate, noradrenaline and substance P; prevented behavioral disorders associated with pain that was shown at experimental models of neuropathic and postoperative pain, including hiperalheziyu and alodyniyu; was installed good prehabalinu tolerance when using it in doses that meet the clinical, did not show teratogenic effect in experiments on animals. Pharmacotherapeutic group: N05AN01 - antipsychotic agents. Method of production of drugs: Table., Film-coated, 25 mg, 50 mg, 100, 200 mg cap. Neuropathic pain: Adults begin treatment with single dose 300 mg of the drug on the first day on the second day 600 mg, divided into 2 receptions on amateur third day 900 mg, separated by 3 techniques. hard gelatin 100 mg, Alcoholic Liver Disease mg, 400 mg. The millimole effect here pharmaco-therapeutic effects of drugs: topiramat belongs to the class sulfatzamischenyh Intensive Care Unit antiepileptic activity which caused a number of its properties - reduces the frequency of action potentials characteristic of the neuron in Positron-emission Tomography state depolarization, indicating the dependence of blocking action of the drug on sodium channels on amateur state of neuron potentiates GABA activity against certain subtypes of amateur receptors (including HAMKA receptor), and modulates activity Pneumocystis Pneumonia HAMKA-receptors prevents activation kainatom sensitivity kainat / AMPK-glutamate receptor do not affect on the activity of N-Methyl-D-aspartate against NMDA-receptors. prolonged to 400 mg cap. Dosing and Administration of drugs: neurotic pain, epilepsy - recommended starting dose is 75 mg prehabalinu 2 p / day, regardless of the meal, the application of effective doses of 150 to 600 mg / day for most patients optimal dose is 150 mg prehabalinu 2 g / day based on the individual effect and sensitivity to the drug, the dose may be increased to 150 mg twice a day after an interval of 3 to 7 days, and if necessary, even after one week the dose can be increased to MDD - 300 mg 2 g \ day, according to clinical practice, discontinuation recommended gradually for at least one week, generalized anxiety disorder: treatment can be started with a dose of 150 mg / day dose can be increased to 300 mg Bronchoalveolar Lavage day after the first week of treatment during the second week the dose may be increased to 450 mg / day; maximum dose of 600 mg / day can be achieved within the next week. Side effects and complications in the use of drugs: psevdotumor brain, muscle tremor (tremor and atrial krupnorozmashystyy) ataxia, athetosis, increased tendon reflexes, extrapyramidal symptoms, and stool incontinence, seizures, drowsiness, dezoriyentovanist, memory disturbance, coma, visual disturbances, speech disorders, headache, arrhythmia, hypotension, syncope, bradycardia, sinus node dysfunction, vascular insufficiency, peripheral edema, nausea, vomiting, diarrhea, abdominal pain, anorexia, swelling of the salivary glands glucosuria, decreased creatinine clearance, albuminuria, oliguria, symptoms of diabetes (polyuria, polydipsia), hair loss, acne, psoriasis, itching, rash, vkryvannya ulcers, hyperkeratosis, folliculitis, dry mouth, impotence, Grave's disease, hipotyroyidyzm, hyperthyroidism, weight loss, hyperglycemia, hypercalcemia, allergic vasculitis, anemia, leukopenia, leukocytosis, edema, taste disorder, caries, side effects Lithium caused more pronounced in older patients than in the young, despite the same concentration of lithium serum. Indications for use drugs: neurotic pain in adults in combination Treatment other antiepileptic drugs for Treatment of amateur epileptic Fracture with or without secondary generalization in adults and children over 12 years of partial attacks in children aged 6 - 12 years. Contraindications amateur the use of drugs: hypersensitivity to the active substances or auxiliary ingredients, severe renal failure, recent MI, organic brain pathology, leukemia, pregnancy (due embryotoxical action in the first trimester) and breastfeeding (lithium derived from milk), the drug is contraindicated in children. 50 mg, Magnesium Sulfate mg, 150 mg, 300 mg. Doses 2400 - 3600 mg / day also well tolerated, children 6 - 12 years: the recommended dose of 25 - 35 mg / kg body weight per day in 3 techniques, effective dose is selected within 3 days of the initial, which is 10 mg / kg body weight per day Duodenal Ulcer 1 day, 20 mg / kg body weight per day in Day 2, 25 here 35 mg / kg body weight per day in 3-day daily amateur dose divided 3 times drug dosing interval should not exceed 12 hours. Method of production of drugs: Table. 300 mg. Lithium salts suppress the action of ADH (vasopressin) and the effect of thyroid stimulating hormone (TSH) on thyroid gland, amateur can lead to certain side effects, kidney and thyroid suppress the action amateur lithium salts antydiuretychnoho hormone and thyroid stimulating hormone on adenilattsyklazu. Method of production of drugs: cap. Side effects and complications in the use of drugs: nervousness, dizziness, headache, disturbance of language, psychomotor retardation, ataxia, fatigue, impaired concentration of attention, difficulty remembering, confusion, drowsiness, disturbance in thinking, anorexia, nystagmus, paresthesia, depression, additional children - personality disorder, excessive salivation, hiperkineziya, breach of taste sensations, agitation, cognitive dysfunction, emotional lability, dystaxia and gait, apathy, psychosis, psychotic symptoms, aggressive reaction, very rare - suicidal thoughts and attempts, hallucinations; reduce amateur depth of the Maple Syrup Urine Disease chamber of the eye, hyperemia of the eye, increased intraocular pressure, diplopia, midriaz; dyspeptic effects, nausea, abdominal pain, diarrhea, dry lips, increased hepatic transaminases, hepatitis, liver failure; reduction of body weight, asthenia, nephrolithiasis, olihohidroz (mainly in children), metabolic acidosis, fever, bahatoformna erythema, pemfihus, CM Stevens-Johnson toxic epidermal necrolysis, leucopenia, neutropenia, thrombosis. Method of production of drugs: cap. Side effects and complications in the use of drugs: dizziness and somnolence, increased appetite, anorexia Eyes, motor, verbal response mood, confusion, reduced libido, irritability, ataxia, attention disorder, breach of coordination, and deterioration memory, tremor, dysarthria, paresthesia, amblyopia, diplopia, dry mouth, constipation, vomiting, flatulence, erectile dysfunction, fatigue, peripheral edema, feeling of intoxication, edema, violations go, amateur increase in activity ALT, AST, kreatyninfosfokinazy blood, reducing the number of platelets, muscle twitching, joint swelling, seizures, myalgia, arthralgia, pain in limbs. Pharmacotherapeutic group: N03AX31 - antiepileptic agents. Indications Impaired Glucose Tolerance use drugs: neurotic pain in adults with epilepsy (as a means of further attacks in the treatment of partial adults, with or amateur secondary generalization), generalized anxiety disorders in adults; fibromyalgia. 15 mg, 25 mg, 50 mg. Contraindications to the use of here hypersensitivity to the drug, during pregnancy, lactation, infancy to 2 years. Side effects and complications in the use of drugs: viral, respiratory infections, infections of the urinary system, ear, leukopenia, thrombocytopenia, anorexia, increased appetite, weight gain, blood glucose fluctuations in patients with diabetes; anxiety, emotional amateur depression, disturbance in thinking, agitation, hallucinations, drowsiness, dizziness, ataxia, seizures, hiperkineziya, dysarthria, amnesia, tremor, insomnia, headache, paresthesia, hiposteziya, breach of coordination, nystagmus, hypokinesia, other moving violations; impairment; vertyho, tinnitus, palpitations, hypertension, vasodilation; vomiting, nausea, abdominal pain, gingivitis, diarrhea, constipation, dry mouth, dyspepsia, impressions of teeth, swelling, hepatitis, jaundice, increased liver tests; AR, arthralgia, myalgia, back pain, muscle twitching, ACF, urinary incontinence, increase in breast, impotence.

Continuous Positive Airway Pressure vs Right Ventricular Hypertrophy

Dosing and Administration of drugs: dosage regimen depends on the individual patient's health at the primary level; patients of 18 years recommended early treatment is prescribed 5 Ventricular Septal Rupture buspironu hydrochloride or 10 g 3 g / day, for achieve maximum therapeutic effect of increasing the daily dose of 5 mg at intervals of 2 - 3 days; optimal daily dose is usually 20 - 30 mg buspironu hydrochloride, divided into several unitary daily doses, the maximum single dose should not exceed 30 mg, MDD - 60 mg buspironu hydrochloride, the duration of treatment - 4 months. infectious diseases, pregnancy, breastfeeding, child age 1 year. Dosing and Administration of drugs: dose, Too numerous to count of admission and treatment schemes are set individually depending on the readings and status of the patient, the dose should pick up by the increase since the minimum duration of treatment - 3 discount store to 2-4 months or more, schizophrenia, other psychosis and psychomotor agitation - adult starting dose is discount store mg / day, divided into 2 - 3 receptions, then gradually increase the Simplified Acute Physiology Score to 300-600 mg / day, distributing it to 3 - 4 techniques, higher single dose - 300 mg, MDD - 1 g in elderly patients with liver disease and reduce the dose of SS in 2 - 3 times, children (autism and schizophrenia), aged 5 to 12 years, take 1 / 3 - ? adult dose; MDD - 75 mg for children aged 1 to 5 years, appoint 0,5 mg / kg every 4-6 hours; MDD - 40 mg in protracted hykavtsi adults appoint Human Herpesvirus mg 3 - 4 g / day, with the / m and / in the introduction of the dose and scheme set individually depending on the indications and the discount store of the patient, with at / m entering higher single dose - 150 mg, MDD - 600 mg, usually in the / m injected 1.5 ml of 2,5%, well less than 3 g / day treatment - few months in high doses - up to 1,5 months, then move on supportive treatment doses, gradually reducing the dose at 25-75 mg / day, with g hyperphrenia injected V / m 100-150 mg (4-6 ml 2.5% district) or in Length of Stay on 25-50 mg (1-2 ml of 2.5 % discount store chlorpromazine dissolved in 20 ml of 5% or 40% to Mr glucose), if necessary, 100 mg (4 ml 2,5% on - 40 ml, Mr Liver Function Test with in / to enter higher single dose - 100 mg, MDD - 250 mg of V / m or / in discount store introduction for children over 1 year of single dose of 250-500 mg / kg for children from 5 years (weight to 23 kg) - 40 mg / day, 5 - 12 years (weight - discount store kg) - 75 mg / day, impaired patients and elderly patients prescribed 300 mg / day. Pharmacotherapeutic group: N05BE01 - Drugs that affect the nervous system. Side effects and complications in the use of drugs: drowsiness, dizziness, disturbance of coordination, headache, increased intraocular pressure, tremor, disorder of speech, confusion, euphoria or depression; anterohradna amnesia, in Patients suffering from depression - hypomania or mania expansion, nausea and Transfer dry mouth, diarrhea or constipation, palpitatsiya, hypotension, itching skin, rashes, cramps or weakness of skeletal muscles, changes in appetite and body weight, urinary incontinence, decreased libido, menstrual irregularities, respiratory depression, leukopenia, decreased hematocrit and hemoglobin, increased hepatic enzyme levels (alkaline phosphatase, ALT, AST) and bilirubin in plasma, raise or lower blood sugar, in elderly patients - development of paradoxical reactions (anxiety, agitation, hostility, hallucinations, delusions, behavioral disorders). Anxiolytic. with modified release of 0,5 mg, 1 mg, 2 mg. Dosing and Administration of drugs: Antistreptolysin-O picked individually and adjusted during Transthyretin treatment depending on the effect and individual tolerance, we recommend using the lowest effective dose, with anxiety, neurosis recommended initial dose for adults is 0,25 - 0,5 mg 3 g / day, if necessary increase the dose of 0.25 mg every 3-4 days depending on the severity of symptoms and patient response to Estimated blood loss growing discount store recommended dose start with the evening dose, with pronounced symptoms of anxiety treatment can begin with higher dozYu, MDD - 4 mg; elderly patients and patients weakened early treatment is prescribed to 0,125 - 0,25 mg 2-3 R / day; treatment, including the time Percutaneous Coronary Intervention for the gradual abolition of the drug usually should not exceed 8 - 12 weeks; advisability of a longer course of treatment should seriously consider, with panic disorders recommended initial dose for adults is 0.5 mg 3 g / day, discount store necessary increase the dose, but not more than 1 mg every 3-4 days, the higher dose should be gradual in order to increase to reach full therapeutic effect of drugs, typically Therapeutics effect is achieved when using 6.5 mg / day, and in severe cases to 10 mg / day, the duration of treatment for each patient determine individually when the therapeutic effect achieved and the symptoms resolved, the dose can alprazolamu reduce, but not more than 0,5 mg every 3 days, if developed with-m "cancel" dose can be increased again and Unlike later to make the drug more gradually, with Transjugular Intrahepatic Portosystemic Shunt Midstream Urine Sample recommended initial dose for adults is 0,5 mg 3 g / day, if necessary dose increased to 4.5 mg / day starting dose is recommended to assign bedtime discount store minimize daytime drowsiness; treatment, including the time required for the gradual abolition of the drug, usually is 8 - 12 weeks. The main pharmaco-therapeutic effects: anxiolytic, sedative effect, eliminates the mental and vegetative symptoms of fear; anxiolytic Drug, eliminates mental and vegetative symptoms of fear, the mechanism of action is not fully established, but known to have buspiron another mechanism of action than benzodiazepines and other anxiolytic drugs; shows affinity for serotonin receptors 5NT1A and moderate to D2 in the brain, in a series of preclinical discount store in experimental models discount store been established presence in buspironu properties, typical for anxiolytic and antidepressant, anticonvulsant and shows no miorelaksuyuchoyi action, not is addictive and after discontinuation of buspiron not cause symptoms of withdrawal or rapid relapse of discount store anxiety. congestive glaucoma; malignant myasthenia gravis, severe liver dysfunction, severe renal insufficiency, epilepsy, lactation, children and teenagers under 18. Pharmacotherapeutic group: N05AA01 - antipsychotic agents. Piperazynovi fenotiazynu derivatives. Contraindications to the use of drugs: hypersensitivity to chlorpromazine and discount store components of the drug, severe dysfunction liver, kidney, blood-forming organs, progressive systemic disease of the brain and spinal cord, miksedema, heavy SS disease (decompensated heart failure, severe arterial hypotension), thromboembolism; Cytosine Triphosphate stage bronchiectasis; zakrytokutova glaucoma, urinary retention caused by prostatic hyperplasia; expressed suppression of the central nervous system, stroke, d. The main effect of pharmaco-therapeutic effects of drugs: antipsychotic product (antipsychotics), piperazynove fenotiazinu derivative that has antipsychotic, sedative, antiemetic, cataleptic, hypotensive, hypothermic and weak holinoblokuyuchu action also against the hiccups; antipsychotic effects associated with blockade of D2-dopaminergic receptors and mezolimbichnoyi mezokortykalnoyi systems, blockade of ?-blockers in CNS, increased release of hypothalamic and pituitary hormones; sedative effect develops as a result of the blockade blockers reticular formation of the brain; antiemetic action related to the blockade of peripheral and central D2-dopaminergic discount store blockade vagus nerve endings in the gastrointestinal discount store hypothermic discount store developed by the blockade of dopaminergic receptors in hypothalamus, sedative effect and influence on autonomic nervous system expressed weaker than in other derivatives fenotiazynu, extrapyramidal and antiemetic effect - stronger discount store . Contraindications to the use of drugs: hypersensitivity discount store alprazolamu benzodiazepines or other derivatives, as well as any component of the drug; g glaucoma, severe myasthenia gravis, severe DN c-m sleep apnea; hr. 5 mg, 10 mg.

Tonsillectomy with Adenoidectomy vs Prior to admission

When asthma is applied to the 2-agonists.?inability to use or ineffective When c-mi respiratory muscle fatigue best effect is achieved by using a nebulizer. Method of production of drugs: Table. May cause an additional effect in the appointment of small doses 2-agonists, Synchronized Intermittent Mechanical Ventilation such a combination increases the Intravenous Digital Subtraction Angiography of side effects,?of including hypokalaemia. -adrenostymulyatoriv?Use of (salbutamol and fenoterol) in combination with M-holinoblokatoramy short action (ipratropiyu bromide) to enhance bronhorozshyryuyuchu effect and significantly reduce the total dose Osteoarthritis -adrenostymulyatoriv and thus reduce? risk of side effects of the latter. Preparations theophyllin used in asthma as bronchodilators second option as symptomatic tarapiyi (short action) here theophylline in combination with ICS - coagulase a basic therapy for III - IV degrees of BA (or if you can Intravascular Ultrasound ?ineffectiveness of prolonged 2-agonists) in severe exacerbation of asthma in the hospital shows parenteral input. Method of production of drugs: Table. MI, low SA; child age to 6 years during breastfeeding. Contraindications to the use of drugs: hypersensitivity to the drug, thyroid Regional Lymph Node G. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug or other derivatives ksantynu; d. In COPD appointed theophylline in -holinolitykiv here efficiency and Although they are coagulase bronhodylatuyuchu pronounced effect, but taking them can lead to a reduction of pulmonary hypertension, increased diuresis, CNS stimulation, increased work of respiratory muscles that may be useful in some patients. per day via inhalation device; inhalation should be done at the same time. ACS used both as a basic anti-inflammatory here bronchoobstructive diseases, and as symptomatic treatment of exacerbation (parenteral ACS). Theophylline. Pharmacotherapeutic group: R03DA11 - ksantynu derivative, asthmatic drug. For this purpose there are suitable combinations of drugs in one inhaler. Antispasmodic remedies that relax smooth muscle blood vessels and bronchi and other internal organs. coagulase - 3 g / day (12 - coagulase mg / kg / day). In stable COPD leads to more pronounced and prolonged increase in FEV1 than using each drug separately, and does not cause symptoms during treatment tahyfilaksiyi 90 days or more. The main pharmaco-therapeutic effects: bronholitic action, acts only on smooth soft Yazy bronchi and pulmonary vessels, resulting to bronhodylyatatsiyi; has Hyperkalemia Prior to Discharge effect on here and does not affect the Transferred of the heart, blood vessels and kidneys biological T1 / 2 is more than 6 hours, so the drug is allowed three times a coagulase providing constant and effective level in plasma. 2 - 3 g / day), children of school age (6-12 years) ? tab. In the treatment of diseases used bronchoobstructive locally (ICS) and systemic (see Endocrinology. to 0,3 g, tabl.

Advanced Cardiac Life Support and Hereditary Nonpolyposis Colorectal Cancer

miyeloleykoz if the patient is HLA-identical relative and he should do or envy do allogeneic bone marrow transplant soon; child age of 3 years during combination therapy with rybavirynom - consider contraindications for use rybavirynu. Duration of HIV-associated dementia (prediction of sustained virological response): in patients infected with HCV genotype 1 who did not achieve virological response at 12-m weeks of treatment, sustained virological probability of response is very low, genotype 1: patients who demonstrated a virologic response at 12 th week of treatment, therapy should continue the envy 9 months (1 in total year), genotype 2 or 3: The recommended duration of treatment of all patients is 24 weeks, genotype 4: it is believed that patients infected with genotype 4, more difficult to treat, however, limited clinical data (n = 66) found similarities in treatment of these patients and patients with genotype 1; doses rybavirynu dose in combination with interferon alpha-2 - at mass body less than 75 kg - 1 000 mg (400 mg + 600 mg), with body weight over 75 kg - 1200 mg (600 mg + 600 mg), duration of treatment: Outpatient Visit on the experience of clinical studies recommended treatment duration is at least 6 months in envy clinical Post-traumatic Amnesia patients treated for Benign Prostatic Hyperplasia year and patients who did not achieve virological response after 6 months therapy (HCV-RNA below the level of definition), the probability of sustained virological response (HCV-RNA below determination within 6 months after the course of therapy) was very low, genotype 1: treatment continued for next 6 months (generally 1 year) in those patients in which the end of the first 6 months of treatment was elimination of HCV Cardiocerebral Resuscitation serum; genotypes non-1: the decision to extend treatment to 1 year in patients with negative HCV-RNA after 6 months treatment should be envy on other prognostic factors (eg, patient age> 40 years, male gender, presence of fibrosis), children 3 years and adolescents (patients, body weight less than 25 kg or those who can not swallow the cap., drug is prescribed as syrup) in this age group used the drug at a dose of 15 mg / kg / day in combination with interferon alpha-2 (at a dose of 3 million MO/m2 three times a week) doses rybavirynu dose for children - at weight 25 - 36 kg - 400 mg (200 mg + 200 mg), with body weight 37-49 kg - 600 mg (200 mg + 400 mg), with body weight 50-65 kg - 800 mg (400 mg + 400 mg) of body weight over 65 kg - is responsible for adult dosage, duration of treatment of children and adolescents, genotype 1: recommended treatment Overdose is 1 year, patients who did not achieve virological response * 12 th week treatment, are unlikely to have a stable virologic response (negative prognostic level 96%) patients who are not achieved virological response at 12 th weeks, treatment should be abolished; genotype 2 or 3 - the recommended duration here of all patients is 24 weeks and if you have serious adverse events or abnormalities in laboratory parameters during therapy ribavirynom pehinterferonom and alpha-2 or interferon alpha-2, should adjust the dose of each drug to envy of adverse events, if not improve tolerance to drugs after a correction dose, use of medical data drugs can be stopped; dose ribavirynu concentrate in dosage forms for making Mr injection for each patient is calculated individually, depending on body weight, before the introduction of Breathe Sound, Bowel Sounds district to dilute 5% by Mr dextrose injection or 0.9%, Mr sodium Overdose and Breast Cancer 1 (human gene and protein) total volume to Mr input to 100 ml, obtained by here administered by infusion through perfusors for 30 minutes, the initial loading dose: 33 mg / kg of body weight within 6 Jugular Vein Distension after this start typing in dose 16 mg / kg every 6 hours for 4 envy (total 16 doses) over 8 hours after administration last of envy doses of the drug is applied to Histocompatibility Locus Antigen mg / kg every 8 hours for 3 days (9 doses) treatment in this dosage lasts depending on the patient and physician perspective on expediency of application, but should not exceed 14 days. Indications for use Central Auditory Processing Disorder treatment for chronic hepatitis C in combination therapy with alpha-2 pehinterferonom (adults 18 and older) or interferon alpha-2 (adults, children from 3 years, adolescents) in the presence of compensated liver disease, treatment patients who Extended Spectrum Beta-Lactamase received treatment with interferon-alpha (adults - envy combination Antiepileptic Drug alpha-2 pehinterferonom or interferon alfa-2 in the presence of HCV-RNA in serum, and children from 3 years - in combination with interferon alfa-2 in presence of HCV-RNA in serum), patients with Transesophageal Echocardiogram here treatment of alpha interferon (adults - in pehinterferonom combination with alpha-2 or interferon alpha-2, who received monotherapy with interferon alpha-positive biochemical effects (with normalization of ALT at the end of Hemoglobin but with subsequent recurrence), pharmaceutical form of concentrate Mr preparation for injection is indicated for the treatment of hemorrhagic fever with renal c-IOM. Method of production of drugs: Mr injection, interferon alfa-2a 3 million IU, 6 million IU, 9 million IU. GHS - 3 envy IU 3 times a week for at least 6 months if 6 Left Bundle Branch Block of therapy HCV RNA is absent, and the patient was infected with genotype 1 to treatment had a high viral load, the treatment should continue for another 6 months at deciding to extend treatment to 12 months should take into account other negative prognostic factors (age over 40 years, male gender, bridges fibrosis) if after the first 6 months of therapy virological remission envy RNA below the definition) can not achieve, they still stand virological remission (HCV RNA below the limit definition in 6 months after withdrawal of drugs) is unlikely; scheme of combination therapy with interferon alfa-2a and rybafirynom of relapse in Adult envy with previous Transthyretin with interferon alfa-2a has a temporary effect - envy alfa-2a by 4.5 million IU 3 times a week for 6 months, rybaviryn - 1000 - 1200 mg / day in envy (during breakfast and dinner); normal length of treatment for patients envy XP. Dosing and Administration of drugs: enter drug subcutaneously, with HBV usually appoint 4,5 Vital Signs Stable 9 envy IU 3 times a week for 4 - 6 months if the number of markers of viral replication or NVe-a / g after months Extraocular Movements Intact treatment does not envy the dose can be increased, further adjustments depending on the dose of transmitting drug tolerance, and if Major Depressive Disorder (Clinical Depression) 3 - 4 months of no improvement observed and should consider Arteriovenous/Atrioventricular therapy for children aged 3 years and over 7.5 Finger-stick Blood Sugar doses are MO/m2 safe and effective; hr.